articleInsecta mundiSep 1, 2005Closed access

Vagus Nerve Stimulation for Treatment-Resistant\nDepression: A Randomized, Controlled Acute\nPhase Trial

The University of Texas Southwestern Medical Center · Baylor College of Medicine · +17 more institutions

Abstract

Background: Vagus nerve stimulation (VNS) alters both concentrations of neurotransmitters or their metabolites and functional activity of central nervous system regions dysregulated in mood disorders. An open trial has suggested efficacy.\nMethods: This 10-week, acute, randomized, controlled, masked trial compared adjunctive VNS with sham treatment in 235 outpatients with nonpsychotic major depressive disorder (n = 210) or nonpsychotic, depressed phase, bipolar disorder (n = 25). In the current episode, participants had not responded adequately to between two and six research-qualified medication trials. A two-week, single-blind recovery period (no stimulation) and then 10 weeks of masked active or sham VNS…

Citation impact

683
total citations
FWCI
38.16
Percentile
100%
References
42
Citations per year

Authors

16

Topics & keywords

Keywords
  • Vagus nerve stimulation
  • Depression (economics)
  • Treatment-resistant depression
  • Randomized controlled trial
  • Hamilton Rating Scale for Depression
  • Psychology
  • Adverse effect
  • Major depressive disorder
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.